Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders

Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders

Abstract Background Chronic hepatitis C (CHC) is one of the most important comorbidities in patients with hereditary bleeding disorders (HBD). The present study aimed at evaluating the effectiveness of direct-acting antiviral agent (DAA)-based interferon-free HCV antiviral regimens in patients with...

Full description

Bibliographic Details
Main Authors: Heidar Sharafi, Bita Behnava, Alireza Azizi-saraji, Ali Namvar, Ali Anvar, Shima Salimi, Seyed Moayed Alavian
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Virology Journal
Subjects:
Chronic hepatitis C
Direct-acting antiviral agents
Hereditary bleeding disorders
Sofosbuvir
Daclatasvir
Ledipasvir
Online Access:https://doi.org/10.1186/s12985-021-01659-0

Internet

https://doi.org/10.1186/s12985-021-01659-0

Similar Items